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ABSTRACT
Objectives: Synthesis of newer 3,4,6,7-tetrahydro-3,3,6,6-tetramethyl-9-(2-chloro-6-substituted-quinolin-3-yl)-acridine-1,8(2H,5H,9H,10H)-diones 
were synthesized by reacting 5,5-dimethylcyclohexane-1,3-dione with substituted 2-chloro-quinoline-3-carbaldehyde in presence of ammonium 
acetate.
Methods: Synthesis was carried out by microwave irradiation method and the synthesized compounds have been characterized using elemental 
analysis, FT-IR, 1H NMR, and 13C NMR spectroscopy and further supported by mass spectroscopy. Purity of all the compounds has been checked on thin 
layer chromatographic plate and high-performance liquid chromatography technique. All the synthesized compounds were tested for antibacterial 
and anthelminthic activities.
Results: The results were revealed that the compounds AQ-4 and AQ-5 have showed good activity against both Gram-positive and Gram-negative 
bacteria. Compounds AQ-4 and AQ-5 showed moderate activity against all the organisms. However, all the derivatives have shown less antibacterial 
activity when compared to the standard drug amikacin. The compounds AQ-3 and AQ-5 showed good anthelminthic activity and compounds AQ-9 and 
AQ-10 showed moderate anthelminthic activity. However, all the compounds have shown less anthelmintic activity when compared to the standard 
drug albendazole.
Conclusion: The study reveals that compounds containing quinoline derivatives with acridine moiety shown the antibacterial activity against the 
pathogens Bacillus subtilis, Bacillus cereus, Staphylococcus epidermidis, Salmonella typhi, Pseudomonas aeruginosa and Klebsiella pneumoniae. These 
derivatives also possess the good anthelmintic activity. The above green synthesis technique could be a right solution for industrial applications in the 
future and therapeutic needs.
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INTRODUCTION
Quinoline or 1-aza-napthalene or benzo[b]pyridine is nitrogen-
containing heterocyclic aromatic compound. Quinoline is a weak 
tertiary base. It can form salt with acids and displays reactions similar 
to those of pyridine and benzene. It shows both electrophilic and 
nucleophilic substitution reactions. It is nontoxic to humans on oral 
absorption and inhalation. The synthesis of heterocyclic compounds 
has always drawn the attention of chemists over the years mainly 
because of their important biological properties. The heterocyclic 
compound quinoline is one of the most attractive frameworks with 
a wide range of biological and pharmacological activities. This 
physiologically important nucleus is abundantly found in therapeutic 
agents. A large number of heterocyclic compounds containing the 
quinoline ring are associated with diverse pharmacological properties 
such as analgesic [1], antibacterial [2], antioxidant [3], antimalarial [4], 
antifungal [5], anti-inflammatory [6,7], anticancer [8], antiviral [9,10], 
anthelminthic [11], antihypertensive [12], cardiovascular [13], 
central nervous system activity [14] antidiabetic [15], and anti-HIV 
activities [16]. Considering the above observations and in connection 
to previous publications involving the synthesis of new biologically 
active heterocycles. Thus, the efficient synthesis novel series of newer 
quinoline derivatives containing acridine moiety still represent highly 
pursued target.
METHODS
Melting points were determined in open capillary tubes and are 
uncorrected. Formation of the compounds was checked by thin-layer 
chromatography (TLC) on silica gel-G plates of 0.5 mm thickness and 
spots were located by iodine and ultraviolet light. All compounds were 
purified by recrystallization with suitable organic solvents. IR spectra 
were recorded on Brooker-ALPHA FT-IR instrument using KBr pellet 
method. Mass spectra were recorded on Shimadzu GC-MS-QP-2010 
model using direct inlet probe technique. 1H NMR and 13C NMR was 
determined in CDCl3 solution on a Bruker AC-400 MHz spectrometer. 
Purity of the synthesized compounds was checked by high-performance 
liquid chromatography agilent. The results are in agreements with 
the structures assigned. Elemental analysis of the all the synthesized 
compounds was carried out on Euro EA 3000 elemental analyzer and 
the results are in agreements with the structures assigned.
Synthesis of substituted 2-chloro-quinoline-3-carbaldehydes
A Vilsmeier-Haack adduct prepared from phosphorus oxytrichloride 
(6.5 ml, 70 m/mol) and N,N-dimethyl formamide (2.3 ml, 30 m/mol) 
was added to acetanilide derivatives (1.35 g, 10 m/mol), heated at 90°C 
for 3-5 minutes in microwave irradiation. The mixture was then poured 
onto ice, and the white product was collected and dried. The compound 
was purified by recrystallization from petroleum ether.
General procedure for the synthesis of 3,4,6,7-tetrahydro-3,3,6,6-
tetramethyl-9-(2-chloro-6-substituted-quinolin-3-yl)-acridine-
1,8(2H,5H,9H,10H)-dione (AQ-1 to AQ-10)
A mixture of the 5,5-dimethylcyclohexane-1,3-dione (0.01 mol), 
substituted 2-chloro-quinoline-3-carbaldehyde (0.005 mol) and 
ammonium acetate (0.08 mol) was irradiated under microwave 
irradiation at 120°C for 2-3 minutes. The microwave irradiation 
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was operated in 30 seconds cycles. The progress of the reaction was 
monitored by TLC. On completion of the reaction, the reaction mass was 
poured into ice-cold water, the product was filtered, washed with water, 
dried and crystallized from ethanol-DMF (9:1) mixture.
9-(2-chloro-6-fluoroquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8-(2H,5H,9H,10H)-dione (AQ-1)
Yield: 75%; M.P. 209-211°C; IR (cm-1): 3282 (N-H stretching of 
secondary amine), 3074 (C-H stretching of aromatic ring), 2955 
(C-H asymmetrical stretching of CH3 group), 2875 (C-H symmetrical 
stretching of CH3 group), 1629 (C=O stretching of carbonyl group), 
1599, 1491 and 1454(C=C stretching of aromatic ring), 1454 (C-H 
asymmetrical deformation of CH3 group), 1359 (C-H symmetrical 
deformation of CH3 group), 1018 (C-F stretching),958 (C-H in plane 
bending for aromatic ring); 1H NMR (dimethylsulfoxide [DMSO]-d6) δ 
ppm: 0.98 (s,6H, Ha, a’), 1.08 (s, 6H, Hb, b’), 2.07-2.24 (m, 4H, Hc, c’), 
2.41-2.51 (m, 4H, Hd, d’), 4.62(s, 1H, He), 7.74-7.77 (m, 1H, Hf), 7.11-
7.16 (m, 1H, Hg), 7.30-7.33 (m, 1H, Hh), 8.00 (s, 1H, Hi), 11.43 (s, 1H, 
Hj); MS: m/z 452; Anal. Calcd. for C26H26ClFN2O2: C, 68.94; H,5.79; N, 
6.18. Found: C, 68.86; H, 5.72; N, 6.11%.
9-(2,7-dichloroquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8-(2H,5H,9H,10H)-dione (AQ-2)
Yield: 72%; M.P. 237-239°C; MS: m/z 469; Anal. Calcd. for C26H26Cl2N2O2: 
C, 66.53; H, 5.58; N, 5.97. Found: C, 66.46; H, 5.50; N, 5.88%.
9-(2,6-dichloroquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8-(2H,5H,9H,10H)-dione (AQ-3)
Yield: 79%; M.P. 243-245°C; IR (cm−1): 3290 (N-H stretching of 
secondary amine), 3079 (C-H stretching of aromatic ring), 2958 
(C-H asymmetrical stretching of CH3 group), 2872 (C-H symmetrical 
stretching of CH3 group), 1653 (C=O stretching of carbonyl group), 
1614 (N-H deformation of -NH group), 1577 and 1450 (C=C stretching 
of aromatic ring), 1425(C-H asymmetrical deformation of CH3 group), 
1363 (C-H symmetrical deformation of CH3 group), 1004 (C-H in plane 
bending for aromatic ring), 735 (C-Cl stretching); 1H NMR (DMSO-d6) 
δ ppm: 0.87 (s, 6H, Ha, a’), 0.99 (s, 6H, Hb, b’), 1.98-2.53 (m, 8H, Hc, c’, 
d, d’), 4.49 (s, 1H, He), 7.79-7.83 (d, 2H, Hf, i), 7.40-7.42 (m, 1H, Hg), 
7.17-7.19 (d, 1H, Hh), 11.59 (s, 1H, Hj); MS: m/z 469; Anal. Calcd. for 




Yield: 69%; M.P. 228-230°C; MS: m/z 464; Anal. Calcd. for C27H29ClN2O3: 
C, 69.74; H, 6.29; N, 6.02. Found: C, 69.67; H, 6.21; N, 5.95%.
9-(2-chloro-7-methoxyquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8(2H,5H,9H,10H)-dione (AQ-5)
Yield: 71%; M.P. 249-251°C; MS: m/z 464; Anal. Calcd. for C27H29ClN2O3: 
C, 69.74; H, 6.29; N, 6.02. Found: C, 69.66; H, 6.21; N, 5.96%.
9-(2-chloro-6-methoxyquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8(2H,5H,9H,10H)-dione (AQ-6)
Yield: 78%; M.P. 238-240°C; MS: m/z 464; Anal. Calcd. for C27H29ClN2O3: 
C, 69.74; H, 6.29; N,6.02. Found: C, 69.67; H, 6.20; N, 5.94%.
9-(2-chloro-7-methylquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8-(2H,5H,9H,10H)-dione (AQ-7)
Yield: 70%; M.P. 182-184°C; MS: m/z 448; Anal. Calcd. for C27H29ClN2O2: 
C, 72.23; H, 6.51; N,6.24. Found: C, 72.16; H, 6.43; N, 6.17%.
9-(2-chloro-6-methylquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8(2H,5H,9H,10H)-dione (AD-8)
Yield: 76%; M.P. 217-219°C;; IR (cm−1): 3252 (NH stretching of 
secondary amine), 3045 (C-H stretching of aromatic ring), 2955 
(C-H asymmetrical stretching of CH3 group), 2879 (C-H symmetrical 
stretching of CH3 group), 1660 (C=O stretching of carbonyl group), 
1566, 1500 and 1467(C=C stretching of aromatic ring), 1427 (C-H 
asymmetrical deformation of CH3 group), 1365 (C-H symmetrical 
deformation of CH3group), 1066 (C-H in plane bending for aromatic 
ring); 1H NMR (DMSO-d6) δ ppm: 0.93 (s, 6H, Ha, a’), 1.03 (s,6H, Hb, 
b’), 2.01-2.19 (m, 4H, Hc, c’), 2.36-2.50 (m, 4H, Hd, d’), 4.55 (s, 1H, 
He), 7.90-7.91 (d, 1H, Hf), 7.09-7.15 (m, 2H, H g, h), 8.13 (s, 1H, 
Hi), 11.25 (s, 1H, Hj), 2.31 (s, 3H,Hk); MS: m/z 448; Anal. Calcd. for 




Yield: 72%; M.P. 226-228°C; MS: m/z 479; Anal. Calcd. for C26H26ClN3O4: 
C, 65.06; H, 5.46; N,8.76. Found: C, 64.97; H, 5.39; N, 8.70%.
9-(6-bromo-2-chloroquinolin-3-yl)-3,4,6,7-tetrahydro-3,3,6,6-
tetramethylacridine-1,8 (2H,5H,9H,10H)-dione (AQ-10)
Yield: 74%; M.P. 247-249°C; MS: m/z 513; Anal. Calcd. for C26H26BrClN2O2: 
C, 60.77; H, 5.10; N,5.45. Found: C, 60.69; H, 5.03; N, 5.38%.
Biological evaluation
Antibacterial activity
Antibacterial activity of the synthesized compounds was determined, 
using a slightly modified cup plate method. Muller Hinton agar was 
used for the growth of bacterial strains Bacillus subtilis (MTCC 121), 
Bacillus cereus (ATCC 14579), Staphylococcus epidermidis (ATCC 
25923), Salmonella typhi (MTCC 733), Pseudomonas aeruginosa (MTCC 
741) and Klebsiella pneumoniae (ATCC 29212). Each organism was 
suspended in normal saline solution and transmittance (T) of 75-
77% at 530 nm was made, which is equal to 106 CFU/ml. All the test 
compounds were dissolved in DMSO at a concentration of 2 mg/ml. 
Each plate was inoculated with 20 µl of microbial suspension. 100 µl 
of the test compounds was added to each cup. The plates containing 
bacteria were incubated at 37°C for 24 hrs, the positive antimicrobial 
activity were read based on the growth inhibition zone and compared 
with the solvent as a negative control and amikacin as comparative 
drug.
Anthelmintic activity
Indian adult earthworms (Pheretima posthuma) were used to 
study anthelmintic activity. The earthworms (collected from the 
water logged areas of soils, Mangalagiri, Guntur, Andhra Pradesh) 
were washed with normal saline to remove all fecal materials. 
The earthworms in 4-5 cm. in length and 0.1-0.2 cm in width were 
used for all experimental protocol. The earthworm resembles both 
anatomically and physiologically to the intestinal roundworm 
parasites of human beings, hence can be used to study anthelmintic 
activity. The newly synthesized compounds were tested for 
anthelmintic activity. P. posthuma of nearly equal size were selected 
randomly for present study. The worms were acclimatized to the 
laboratory condition before experimentation. The earthworms were 
divided into four groups of six earthworms in each. Albendazole 
diluted with normal saline solution to obtain 0.2% w/v and 0.5% w/v 
served as standard and poured into petri dishes. The synthesized 
compounds were prepared in minimal quantity of DMSO and diluted 
to prepare two concentrations, i.e., 0.2% w/v, 0.5% w/v for each 
compound. Normal saline served as negative control. Six earthworms 
nearly equal size are taken for each concentration and placed in petri 
dishes at room temperature. The time taken for complete paralysis 
and death are recorded. The mean paralysis time and mean lethal time 
for each sample was calculated. The time taken for worms to become 
motionless was noted as paralysis time and to ascertain death, each 
worm was frequently applied with external stimuli which stimulates 
and induce movement in the earthworms, if alive.
RESULTS AND DISCUSSION
3,4,6,7-tetrahydro-3,3,6,6-tetramethyl-9-(2-chloro-6-substituted-
quinolin-3-yl)-acridine-1,8(2H,5H,9H,10H)-dione derivatives were 
synthesized by reacting the 5,5-dimethylcyclohexane-1,3-dione 
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with substituted 2-chloro-quinoline-3-carbaldehyde in presence of 
ammonium acetate as per the Scheme 1. The physical data of the 
synthesized compounds are given in Table 1.
Antibacterial activity
From the antibacterial screening, it was observed that all the compounds 
exhibited activity against all the organisms employed as indicated in 
Table 2. The compounds AQ-4 and AQ-5 have showed good activity 
against both Gram-positive and Gram-negative bacteria. Compounds 
AQ-4 and AQ-5 showed moderate activity against all the organisms. 
Compounds AQ-3 and AQ-10 showed less activity among all the 
synthesized compounds. However, all the derivatives have shown less 
antibacterial activity when compared to the standard drug amikacin.
Anthelmintic activity
The result of anthelmintic activity exhibited by compounds on 
P. posthuma is shown in Table 3. The compounds AQ-3 and AQ-5 showed 
good activity and compounds AQ-9 and AQ-10 showed moderate activity 
Table 1: Physical data of newer quinoline derivatives containing acridine moiety
Compounds R MF MW MP (°C) Yield (%)
AQ-1 2-chloro-6-fluoroquinolin-3-yl C26H26ClFN2O2 452.95 209-211 75.64
AQ-2 2,7-dichloroquinolin-3-yl C26H26Cl2N2O2 469.40 237-239 72.51
AQ-3 2,6-dichloroquinolin-3-yl C26H26Cl2N2O2 469.40 243-245 79.33
AQ-4 2-chloro-8-methoxyquinolin-3-yl C27H29ClN2O3 464.98 228-230 69.58
AQ-5 2-chloro-7-methoxyquinolin-3-yl C27H29ClN2O3 464.98 249-251 71.62
AQ-6 2-chloro-6-methoxyquinolin-3-yl C27H29ClN2O3 464.98 238-240 78.26
AQ-7 2-chloro-7-methylquinolin-3-yl C27H29ClN2O2 448.98 182-184 70.28
AQ-8 2-chloro-6-methylquinolin-3-yl C27H29ClN2O2 448.98 217-219 76.35
AQ-9 2-chloro-7-nitroquinolin-3-yl C26H26ClN3O4 479.96 226-228 72.32
AQ-10 6-bromo-2-chloroquinolin-3-yl C26H26BrClN2O2 513.85 247-249 74.57
Table 2: Antibacterial activity of newer quinoline derivatives containing acridine moiety
Compounds Zone of inhibition (mm)
Bacillus subtilis Bacillus cereus Staphylococcus 
epidermidis




AQ-1 9 13 10 9 8 7
AQ-2 13 10 13 12 11 10
AQ-3 10 8 12 13 1 9
AQ-4 9 7 12 11 10 9
AQ-5 8 13 10 12 10 9
AQ-6 9 13 10 9 9 8.8
AQ-7 8 11 12 7 9 8
AQ-8 10 8 8 7 11 86
AQ-9 6 8 12 8 11 7.5
AQ-10 13 14 14 15 14 12
Normal saline - - - - - -
Amikacin 22 19 20 22 20 18
Scheme 1: Synthesis of newer quinoline derivatives containing acridine moiety
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while AQ-6 and AQ-8 showed very less activity at both concentrations. 
However, all the compounds have shown less anthelmintic activity 
when compared to the standard drug albendazole.
Statistical analysis of anthelminthic activity
All data were presented as mean ± standard error of the mean 
statistical analysis was performed using the independent Student’s 
t-test. Meantime and statistically significant at P<0.05.
CONCLUSION
In conclusion, the synthesis of newer quinoline derivatives containing 
acridine moiety were achieved by reacting the mixture of the 
5,5-dimethylcyclohexane-1,3-dione, substituted 2-chloro-quinoline-3-
carbaldehyde and ammonium acetate. All the ten synthesized newer 
quinoline derivatives containing acridine moiety were evaluated 
for their antibacterial and anthelminthic activities. Results revealed 
that all the compounds showed good antibacterial and anthelminthic 
activities. The study would be a fruitful matrix for the development 
of newer quinoline derivatives containing acridine moiety for further 
bioevaluation.
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Table 3: Anthelmintic activity of newer acridine derivatives 
containing quinoline moiety








0.2% 0.5% 0.2% 0.5%
AQ-1 3.10 2.08 13 10
AQ-2 11.12 9.10 18 14
AQ-3 2.9 1.50 9 5
AQ-4 15.10 9.50 27 16
AQ-5 11.50 8.45 23 14
AQ-6 38.25 22.60 57 32
AQ-7 5.10 3.5 17 10
AQ-8 6 4.0 14 9
AQ-9 0.50 0.40 8 4
AQ-10 8 6.10 22 16
Normal saline - - - -
Albendazole 0.25 0.18 0.36 0.29
Time of paralysis and death of worms in minutes in the control (normal 
saline). Values are expressed as mean±SEM (n=5). Means significantly different 
at p<0.05 compared with albendazole treated group in each column using 
independent Student’s t-test. SEM: Standard error of mean
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